{"id":4454,"date":"2026-08-30T18:30:00","date_gmt":"2026-08-30T18:30:00","guid":{"rendered":"https:\/\/futurenews24.com\/index.php\/2026\/08\/30\/utm_campaignrss-41\/"},"modified":"2026-08-30T22:59:04","modified_gmt":"2026-08-30T22:59:04","slug":"utm_campaignrss-41","status":"publish","type":"post","link":"https:\/\/futurenews24.com\/index.php\/2026\/08\/30\/utm_campaignrss-41\/","title":{"rendered":"Takeda and Protagonist&#8217;s Mimrylo accredited for polycythemia vera"},"content":{"rendered":"<p><br \/>\n<\/p>\n<div data-author=\"adam-feuerstein\">\n<p class=\"author-bio\">Adam Feuerstein is a senior author and biotech columnist, reporting on the crossroads of drug improvement, enterprise, Wall Avenue, and biotechnology. He&#8217;s additionally a co-host of the weekly biotech podcast The Readout Loud and writer of the publication Adam\u2019s Biotech Scorecard. You may attain Adam on Sign at stataf.54.<\/p>\n<\/div>\n<div>\n<p class=\"wp-block-paragraph\">The Meals and Drug Administration on Friday accredited a brand new remedy for a uncommon and slow-growing most cancers that causes an overproduction of pink blood cells.\u00a0<\/p>\n<p class=\"wp-block-paragraph\">The drug, referred to as rusfertide, was developed by the biotech firm Protagonist Therapeutics. It will likely be offered by Takeda, the Japanese pharma firm, underneath the model identify Mimrylo.\u00a0<\/p>\n<p class=\"wp-block-paragraph\">Administered by way of a weekly injection, Mimrylo was cleared to deal with polycythemia vera, a continual blood most cancers by which overproduction of pink blood cells thickens a affected person\u2019s blood, leading to larger threat for life-threatening coronary heart assaults, strokes, and blood clots.<\/p>\n<div class=\"restricted-content-breaker article\" aria-labelledby=\"restricted-story-heading\" aria-describedby=\"restricted-story-description\" checked=\"false\">\n<div class=\"restricted-content-breaker-bar\">\n<p class=\"restricted-text\">STAT+ Unique Story<\/p>\n<p class=\"restricted-login\">Have already got an account? Log in<\/p>\n<\/p><\/div>\n<p>\t\t\t<img decoding=\"async\" class=\"restricted-content-breaker-bg\" src=\"https:\/\/www.statnews.com\/wp-content\/themes\/stat\/images\/stat-plus-breaker-bg.png\" alt=\"STAT+\"\/><\/p>\n<div class=\"restricted-content-breaker-wrapper\">\n\t\t\t\t<span class=\"stat-paywall-archive\"><\/p>\n<p>\t\t\t\t\t\t<img decoding=\"async\" class=\"stat-plus-logo\" src=\"https:\/\/www.statnews.com\/wp-content\/themes\/stat\/images\/stat-plus-logo-white.svg\" alt=\"STAT+\"\/><\/p>\n<p>\t\t\t\t<\/span><\/p>\n<h2 id=\"restricted-story-heading\">This text is unique to STAT+ subscribers<\/h2>\n<h3 id=\"restricted-story-description\">Unlock this text \u2014 plus day by day protection and evaluation of the biotech sector \u2014 by subscribing to STAT+.<\/h3>\n<p class=\"restricted-content-breaker-wrapper-cta mobile\">Have already got an account? Log in<\/p>\n<div class=\"restricted-content-breaker-cards\">\n<div class=\"slider-container\" aria-label=\"Subscription plan toggle\">\n\t\t\t\t\t\tParticular person plans<\/p>\n<p>\t\t\t\t\t\tGroup plans\n\t\t\t\t\t<\/p><\/div><\/div>\n<p>\t\t\t\tView All Plans\n\t\t\t<\/p><\/div><\/div>\n<div class=\"restricted-message-breaker\">\n<div class=\"restricted-content-wrapper\">\n<div class=\"restricted-content-message\">\n<p class=\"restricted-content-text\">\n\t\t\t\t\t\tTo learn the remainder of this story subscribe to STAT+.\t\t\t\t\t<\/p>\n<p>\t\t\t\t\tSubscribe\n\t\t\t\t\t\t\t\t\t<\/p><\/div><\/div><\/div><\/div>\n<p><br \/>\n<br \/><a href=\"https:\/\/www.statnews.com\/2026\/08\/30\/fda-approves-mimrylo-takeda-protagonist-treatment-for-polycythemia-vera\/?utm_campaign=rss\">Source link <\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Adam Feuerstein is a senior author and biotech columnist, reporting on the crossroads of drug improvement, enterprise, Wall Avenue, and biotechnology. He&#8217;s additionally a co-host of the weekly biotech podcast The Readout Loud and writer of the publication Adam\u2019s Biotech Scorecard. You may attain Adam on Sign at stataf.54. The Meals and Drug Administration on [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":4456,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"fifu_image_url":"https:\/\/www.statnews.com\/wp-content\/uploads\/2026\/08\/AdobeStock_729644280_Editorial_Use_Only-1024x576.jpeg","fifu_image_alt":"","jnews-multi-image_gallery":[],"jnews_single_post":[],"jnews_primary_category":[],"jnews_override_bookmark_settings":[],"jnews_social_meta":[],"jnews_override_counter":[],"footnotes":""},"categories":[10],"tags":[3129,4637,4638,4636,4635,2541],"class_list":["post-4454","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-biotechnology","tag-approved","tag-mimrylo","tag-polycythemia","tag-protagonists","tag-takeda","tag-vera"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Takeda and Protagonist&#039;s Mimrylo accredited for polycythemia vera - Future News 24<\/title>\n<meta name=\"description\" content=\"The FDA approved Mimrylo to treat polycythemia vera, a cancer in which overproduction of red cells thickens a patient\u2019s blood.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/futurenews24.com\/index.php\/2026\/08\/30\/utm_campaignrss-41\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Takeda and Protagonist&#039;s Mimrylo accredited for polycythemia vera - Future News 24\" \/>\n<meta property=\"og:description\" content=\"The FDA approved Mimrylo to treat polycythemia vera, a cancer in which overproduction of red cells thickens a patient\u2019s blood.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/futurenews24.com\/index.php\/2026\/08\/30\/utm_campaignrss-41\/\" \/>\n<meta property=\"og:site_name\" content=\"Future News 24\" \/>\n<meta property=\"article:published_time\" content=\"2026-08-30T18:30:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-08-30T22:59:04+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.statnews.com\/wp-content\/uploads\/2026\/08\/AdobeStock_729644280_Editorial_Use_Only-1024x576.jpeg\" \/>\n<meta name=\"author\" content=\"Future News 24\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/www.statnews.com\/wp-content\/uploads\/2026\/08\/AdobeStock_729644280_Editorial_Use_Only-1024x576.jpeg\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Future News 24\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/futurenews24.com\\\/index.php\\\/2026\\\/08\\\/30\\\/utm_campaignrss-41\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/futurenews24.com\\\/index.php\\\/2026\\\/08\\\/30\\\/utm_campaignrss-41\\\/\"},\"author\":{\"name\":\"Future News 24\",\"@id\":\"https:\\\/\\\/futurenews24.com\\\/#\\\/schema\\\/person\\\/cecad1bde21cfc357cf70128144d6c83\"},\"headline\":\"Takeda and Protagonist&#8217;s Mimrylo accredited for polycythemia vera\",\"datePublished\":\"2026-08-30T18:30:00+00:00\",\"dateModified\":\"2026-08-30T22:59:04+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/futurenews24.com\\\/index.php\\\/2026\\\/08\\\/30\\\/utm_campaignrss-41\\\/\"},\"wordCount\":228,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/futurenews24.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/futurenews24.com\\\/index.php\\\/2026\\\/08\\\/30\\\/utm_campaignrss-41\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.statnews.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/AdobeStock_729644280_Editorial_Use_Only-1024x576.jpeg\",\"keywords\":[\"approved\",\"Mimrylo\",\"polycythemia\",\"Protagonists\",\"Takeda\",\"Vera\"],\"articleSection\":[\"BioTechnology\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/futurenews24.com\\\/index.php\\\/2026\\\/08\\\/30\\\/utm_campaignrss-41\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/futurenews24.com\\\/index.php\\\/2026\\\/08\\\/30\\\/utm_campaignrss-41\\\/\",\"url\":\"https:\\\/\\\/futurenews24.com\\\/index.php\\\/2026\\\/08\\\/30\\\/utm_campaignrss-41\\\/\",\"name\":\"Takeda and Protagonist's Mimrylo accredited for polycythemia vera - Future News 24\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/futurenews24.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/futurenews24.com\\\/index.php\\\/2026\\\/08\\\/30\\\/utm_campaignrss-41\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/futurenews24.com\\\/index.php\\\/2026\\\/08\\\/30\\\/utm_campaignrss-41\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.statnews.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/AdobeStock_729644280_Editorial_Use_Only-1024x576.jpeg\",\"datePublished\":\"2026-08-30T18:30:00+00:00\",\"dateModified\":\"2026-08-30T22:59:04+00:00\",\"description\":\"The FDA approved Mimrylo to treat polycythemia vera, a cancer in which overproduction of red cells thickens a patient\u2019s blood.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/futurenews24.com\\\/index.php\\\/2026\\\/08\\\/30\\\/utm_campaignrss-41\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/futurenews24.com\\\/index.php\\\/2026\\\/08\\\/30\\\/utm_campaignrss-41\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/futurenews24.com\\\/index.php\\\/2026\\\/08\\\/30\\\/utm_campaignrss-41\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.statnews.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/AdobeStock_729644280_Editorial_Use_Only-1024x576.jpeg\",\"contentUrl\":\"https:\\\/\\\/www.statnews.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/AdobeStock_729644280_Editorial_Use_Only-1024x576.jpeg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/futurenews24.com\\\/index.php\\\/2026\\\/08\\\/30\\\/utm_campaignrss-41\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/futurenews24.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Takeda and Protagonist&#8217;s Mimrylo accredited for polycythemia vera\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/futurenews24.com\\\/#website\",\"url\":\"https:\\\/\\\/futurenews24.com\\\/\",\"name\":\"Future News 24\",\"description\":\"The Smart Hub for AI and Next-Gen Innovation\",\"publisher\":{\"@id\":\"https:\\\/\\\/futurenews24.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/futurenews24.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/futurenews24.com\\\/#organization\",\"name\":\"Future News 24\",\"url\":\"https:\\\/\\\/futurenews24.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/futurenews24.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/futurenews24.com\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/fn24-favicon.png\",\"contentUrl\":\"https:\\\/\\\/futurenews24.com\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/fn24-favicon.png\",\"width\":250,\"height\":250,\"caption\":\"Future News 24\"},\"image\":{\"@id\":\"https:\\\/\\\/futurenews24.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/futurenews24.com\\\/#\\\/schema\\\/person\\\/cecad1bde21cfc357cf70128144d6c83\",\"name\":\"Future News 24\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/d57f07142d73cb5503ab2446ea7bc9ef3d0a5ba378d64a6157692311e42bf097?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/d57f07142d73cb5503ab2446ea7bc9ef3d0a5ba378d64a6157692311e42bf097?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/d57f07142d73cb5503ab2446ea7bc9ef3d0a5ba378d64a6157692311e42bf097?s=96&d=mm&r=g\",\"caption\":\"Future News 24\"},\"sameAs\":[\"https:\\\/\\\/futurenews24.com\"],\"url\":\"https:\\\/\\\/futurenews24.com\\\/index.php\\\/author\\\/mridulpahuja20\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Takeda and Protagonist's Mimrylo accredited for polycythemia vera - Future News 24","description":"The FDA approved Mimrylo to treat polycythemia vera, a cancer in which overproduction of red cells thickens a patient\u2019s blood.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/futurenews24.com\/index.php\/2026\/08\/30\/utm_campaignrss-41\/","og_locale":"en_US","og_type":"article","og_title":"Takeda and Protagonist's Mimrylo accredited for polycythemia vera - Future News 24","og_description":"The FDA approved Mimrylo to treat polycythemia vera, a cancer in which overproduction of red cells thickens a patient\u2019s blood.","og_url":"https:\/\/futurenews24.com\/index.php\/2026\/08\/30\/utm_campaignrss-41\/","og_site_name":"Future News 24","article_published_time":"2026-08-30T18:30:00+00:00","article_modified_time":"2026-08-30T22:59:04+00:00","og_image":[{"url":"https:\/\/www.statnews.com\/wp-content\/uploads\/2026\/08\/AdobeStock_729644280_Editorial_Use_Only-1024x576.jpeg","type":"","width":"","height":""}],"author":"Future News 24","twitter_card":"summary_large_image","twitter_image":"https:\/\/www.statnews.com\/wp-content\/uploads\/2026\/08\/AdobeStock_729644280_Editorial_Use_Only-1024x576.jpeg","twitter_misc":{"Written by":"Future News 24","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/futurenews24.com\/index.php\/2026\/08\/30\/utm_campaignrss-41\/#article","isPartOf":{"@id":"https:\/\/futurenews24.com\/index.php\/2026\/08\/30\/utm_campaignrss-41\/"},"author":{"name":"Future News 24","@id":"https:\/\/futurenews24.com\/#\/schema\/person\/cecad1bde21cfc357cf70128144d6c83"},"headline":"Takeda and Protagonist&#8217;s Mimrylo accredited for polycythemia vera","datePublished":"2026-08-30T18:30:00+00:00","dateModified":"2026-08-30T22:59:04+00:00","mainEntityOfPage":{"@id":"https:\/\/futurenews24.com\/index.php\/2026\/08\/30\/utm_campaignrss-41\/"},"wordCount":228,"commentCount":0,"publisher":{"@id":"https:\/\/futurenews24.com\/#organization"},"image":{"@id":"https:\/\/futurenews24.com\/index.php\/2026\/08\/30\/utm_campaignrss-41\/#primaryimage"},"thumbnailUrl":"https:\/\/www.statnews.com\/wp-content\/uploads\/2026\/08\/AdobeStock_729644280_Editorial_Use_Only-1024x576.jpeg","keywords":["approved","Mimrylo","polycythemia","Protagonists","Takeda","Vera"],"articleSection":["BioTechnology"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/futurenews24.com\/index.php\/2026\/08\/30\/utm_campaignrss-41\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/futurenews24.com\/index.php\/2026\/08\/30\/utm_campaignrss-41\/","url":"https:\/\/futurenews24.com\/index.php\/2026\/08\/30\/utm_campaignrss-41\/","name":"Takeda and Protagonist's Mimrylo accredited for polycythemia vera - Future News 24","isPartOf":{"@id":"https:\/\/futurenews24.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/futurenews24.com\/index.php\/2026\/08\/30\/utm_campaignrss-41\/#primaryimage"},"image":{"@id":"https:\/\/futurenews24.com\/index.php\/2026\/08\/30\/utm_campaignrss-41\/#primaryimage"},"thumbnailUrl":"https:\/\/www.statnews.com\/wp-content\/uploads\/2026\/08\/AdobeStock_729644280_Editorial_Use_Only-1024x576.jpeg","datePublished":"2026-08-30T18:30:00+00:00","dateModified":"2026-08-30T22:59:04+00:00","description":"The FDA approved Mimrylo to treat polycythemia vera, a cancer in which overproduction of red cells thickens a patient\u2019s blood.","breadcrumb":{"@id":"https:\/\/futurenews24.com\/index.php\/2026\/08\/30\/utm_campaignrss-41\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/futurenews24.com\/index.php\/2026\/08\/30\/utm_campaignrss-41\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/futurenews24.com\/index.php\/2026\/08\/30\/utm_campaignrss-41\/#primaryimage","url":"https:\/\/www.statnews.com\/wp-content\/uploads\/2026\/08\/AdobeStock_729644280_Editorial_Use_Only-1024x576.jpeg","contentUrl":"https:\/\/www.statnews.com\/wp-content\/uploads\/2026\/08\/AdobeStock_729644280_Editorial_Use_Only-1024x576.jpeg"},{"@type":"BreadcrumbList","@id":"https:\/\/futurenews24.com\/index.php\/2026\/08\/30\/utm_campaignrss-41\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/futurenews24.com\/"},{"@type":"ListItem","position":2,"name":"Takeda and Protagonist&#8217;s Mimrylo accredited for polycythemia vera"}]},{"@type":"WebSite","@id":"https:\/\/futurenews24.com\/#website","url":"https:\/\/futurenews24.com\/","name":"Future News 24","description":"The Smart Hub for AI and Next-Gen Innovation","publisher":{"@id":"https:\/\/futurenews24.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/futurenews24.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/futurenews24.com\/#organization","name":"Future News 24","url":"https:\/\/futurenews24.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/futurenews24.com\/#\/schema\/logo\/image\/","url":"https:\/\/futurenews24.com\/wp-content\/uploads\/2026\/06\/fn24-favicon.png","contentUrl":"https:\/\/futurenews24.com\/wp-content\/uploads\/2026\/06\/fn24-favicon.png","width":250,"height":250,"caption":"Future News 24"},"image":{"@id":"https:\/\/futurenews24.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/futurenews24.com\/#\/schema\/person\/cecad1bde21cfc357cf70128144d6c83","name":"Future News 24","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/d57f07142d73cb5503ab2446ea7bc9ef3d0a5ba378d64a6157692311e42bf097?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/d57f07142d73cb5503ab2446ea7bc9ef3d0a5ba378d64a6157692311e42bf097?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/d57f07142d73cb5503ab2446ea7bc9ef3d0a5ba378d64a6157692311e42bf097?s=96&d=mm&r=g","caption":"Future News 24"},"sameAs":["https:\/\/futurenews24.com"],"url":"https:\/\/futurenews24.com\/index.php\/author\/mridulpahuja20\/"}]}},"_links":{"self":[{"href":"https:\/\/futurenews24.com\/index.php\/wp-json\/wp\/v2\/posts\/4454","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/futurenews24.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/futurenews24.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/futurenews24.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/futurenews24.com\/index.php\/wp-json\/wp\/v2\/comments?post=4454"}],"version-history":[{"count":1,"href":"https:\/\/futurenews24.com\/index.php\/wp-json\/wp\/v2\/posts\/4454\/revisions"}],"predecessor-version":[{"id":4455,"href":"https:\/\/futurenews24.com\/index.php\/wp-json\/wp\/v2\/posts\/4454\/revisions\/4455"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/futurenews24.com\/index.php\/wp-json\/wp\/v2\/media\/4456"}],"wp:attachment":[{"href":"https:\/\/futurenews24.com\/index.php\/wp-json\/wp\/v2\/media?parent=4454"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/futurenews24.com\/index.php\/wp-json\/wp\/v2\/categories?post=4454"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/futurenews24.com\/index.php\/wp-json\/wp\/v2\/tags?post=4454"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}